Neurodegeneration: Diseases of the cytoskeleton?

Cell Death and Differentiation

Volumn 7, Issue 10, 2000, Pages 861-865

  McMurray, C T ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; BIOGENESIS; CELL DEATH; CELL ORGANELLE; CONFORMATIONAL TRANSITION; CYTOPLASM VESICLE; CYTOSKELETON; DEGENERATIVE DISEASE; DNA DAMAGE; EDITORIAL; GENE MUTATION; HUMAN; MICROTUBULE; MITOCHONDRION; NERVE DEGENERATION; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN DEFECT; SYNAPTIC TRANSMISSION;

EID: 0033770166     PISSN: 13509047     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cdd.4400764     Document Type: Editorial

References (69)

1. Alzheimer's disease
2. The beta-amyloid precursor protein and its derivatives: From biology to learning and memory processes
3. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease
4. Candidate gene for the chromosome 1 familial Alzhelmer's disease locus
5. Mutation of the beta-amyloid precursor protein in familial Alzheimer's disease increases beta-protein production
6. Mutant presenilin 1 increases the levels of Alzheimer amyloid beta-peptide Abeta42 in late compartments of the constitutive secretory pathway
7. Intracellular site of gamma-secretase cleavage for Abeta42 generation in neuro 2a cells harbouring a presenilin 1 mutation
8. Notch and presenilins in vertebrates and invertebrates: Implications for neuronal development and degeneration
9. The transmembrane aspartates in presenilin 1 and 2 are obligatory for gammasecretase activity and amyloid beta-protein generation
10. Isolation of human delta-catenin and its binding specificity with presenilin 1
11. Acting like actin. The dynamics of the nematode major sperm protein (msp) cytoskeleton indicate a push-pull mechanism for amoeboid cell motility
12. Deposition of beta/A4 protein along neuronal plasma membranes in diffuse senile plaques
13. Alzheimer-type neuropathology in transgenic mice over-expressing V717F beta-amyloid precursor protein
14. Isoforms of human microtubule-associated protein tau: Sequences and localization in neurofibrillary tangles of Alzheimer's disease
15. Phosphorylation that detaches tau protein from microtubules (Ser262, Ser214) also protects it against aggregation into Alzheimer paired helical filaments
16. Alzheimer-like changes in microtubule-associated protein Tau induced by sulfated glycosaminoglycans. Inhibition of microtubule binding, stimulation of phosphorylation, and filament assembly depend on the degree of sulfation
17. Assembly of microtubule-associated protein tau into Alzheimer-likefilaments induced by sulphated glycosaminoglycans
18. Untangling tau-related dementia
19. FTDP-17: An early-onset phenotype with parkinsonism and epileptic seizures caused by a novel mutation
20. Structure and novel exons of the human tau gene
21. Altered microtubule organization in small-calibre axons of mice lacking tau protein
22. Prominent axonopathy in the brain and spinal cord of transgenic mice overexpressing four-repeat human tau protein
23. Cloning and distribution of the rat parkin mRNA
24. Synphilin-1 is present in Lewy bodies in Parkinson's disease
25. Membrane association and protein conformation of alpha-synuclein in intact neurons. Effect of Parkinson's disease-linked mutations
26. Synuclein shares physical and functional homology with 14-3-3 proteins
27. alpha-synuclein overexpression promotes aggregation of mutant huntingtin
28. Mechanisms for neuronal degeneration in amyotrophic lateral sclerosis and in models of motor neuron
29. Motor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury
30. Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase
31. Kinesin and dynein superfamily proteins and the mechanism of organelle transport
32. Slowing of axonal transport is a very early event in the toxicity of ALS-linked SOD1 mutants to motor neurons
33. The slow component of axonal transport. Identification of major structural polypeptides of the axon and their generality among mammalian neurons
34. Microtubule dysfunction by posttranslational nitrotyrosination of alpha-tubulin: A nitric oxide-dependent mechanism of cellular injury
35. Peroxynitrite studied by stopped-flow spectroscopy
36. Oxidative stress in Huntington's disease
37. DNA secondary structure: A common and causative factor for expansion in human disease
38. Huntington Disease
39. Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions
40. Ataxin-1 nuclear localization and aggregation: Role in polyglutamine-induced disease in SCA1 transgenic mice
41. SCA1 transgenic mice: A model for neurodegeneration caused by an expanded CAG trinucleotide repeat
42. The cerebellar leucine-rich acidic nuclear protein interacts with ataxin-1
43. A nuclear factor containing the leucine-rich repeats expressed in murine cerebellar neurons
44. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain
45. Neuronal distribution of intranuclear inclusions in Huntington's disease with adult onset
46. Nuclear and neurophil aggregates in Huntington's disease: Relationship to neuropathology
47. Wild-type and mutant huntingtins function in vesicle trafficking in the secretory and endocytic pathways
48. Huntingtin localization in brains of normal and Huntington's disease patients
49. Differential distribution of the normal and mutated forms of huntingtin in the human brain
50. Huntingtin is ubiquitinated and interacts with a specific ubiquitin-conjugating enzyme
51. SH3GL3 associates with the huntingtin exon 1 protein and promotes the formation of polygin-containing protein aggregates
52. A huntingtin-associated protein enriched in brain with implications for pathology
53. HIP-1:A huntingtin interacting protein isolated by the yeast two-hybrid system
54. Huntington's disease gene product, huntingtin, associates with microtubules in vitro
55. Interaction of huntingtin associated protein with dynactin p150(Glued)
56. Huntingtin-associated protein 1 (HAP 1) interacts with the p150(Glued) subunit of dynactin
57. Huntingtin interacts with a family of WW domain proteins
58. Huntingtin-associated protein 1 (HAP1) binds to a Trio-like polypeptide, with a rac1 quanine nucleotide exchange factor domain
59. Genetic study of interactions between the cytoskeletal assembly protein sla 1 and prion-forming domain of the release factor Sup35 (eRF3) in Saccharomyces cerevisiae
60. An actin binding protein is a novel component of clathrin-coated pits and vesicles
61. Deficit of in vivo mitochondrial ATP production in patients with Friedreich ataxia
62. GAA instability in Friedreich's Ataxia shares a common, DNA-directed and intraallelic mechanism with other trinucleotide diseases
63. Respiratory chain abnormal function in Huntington's disease chorea
64. Evidence for impairment of energy metabolism in vivo in Huntington's disease using localized 1H NMR spectroscopy
65. Increased apoptosis of Huntington disease lymphoblasts associated with repeat length-dependent mitochondrial depolarization
66. Increased 8-oxo-dGTPase in the mitochondria of substantia nigral neurons in Parkinson's disease
67. The role of p53 in neuronal cell death
68. Neuronal life and death: An essential role for the p53 family
69. Pathogenesis of prion diseases: A progress report